Livia Veress, MD
Professor, Pediatrics-Pulmonary Medicine

Photo
Medical School:
  • MD, Louisiana State University School of Medicine in New Orleans (2002)
Undergraduate School:
  • BS, Tulane University (LA) (1996)
Residency:
  • Louisiana State University Program, Pediatrics (2006)
Fellowships:
  • University of Colorado, Pediatric Critical Care Medicine (2006)
  • University of Colorado, Pediatric Pulmonology (2010)
Languages: English, Hungarian
Department: Pediatrics-Pulmonary Medicine

Professional Titles

  • Director, Center of Advanced Drug Development

Recognition & Awards

  • Poster Competition, Countermeasures Against Chemical Threats (2011)
  • Travel Award, Countermeasures Against Chemical Threats (2011)
  • Travel Award, Countermeasures Against Chemical Threats (2010)
  • Young Faculty Awards, Children's Environmental Health Center (2010)
  • Travel Award, American Thoracic Society (2009)
  • Travel Award, Countermeasures Against Chemical Threats (2009)

Research Interests

My research interests include: Translational research, acute lung injury, bronchiolitis obliterans, interstitial lung fibrosis, pulmonary wound repair and tissue regeneration, chemical inhalation injury, airway coagulation, fibrinolytic and antifibrotic drug therapies, drug development, plastic bronchitis, pulmonary hypertension, pulmonary vascular thrombosis, endothelialitis, microvascular thrombosis, immunothrombosis, severe COVID-19 illness and other pulmonary toxicology.

Publications

  • Bodmer JL, Weinman J, Veress LA, Galambos C. Obstructive Bronchial Fibrin Cast Formation in COVID-19 Severe Respiratory Failure. Am J Respir Crit Care Med. 2022 Sep 29. [Epub ahead of print] PubMed PMID: 36174140
  • Donkor AB, Gyamfi OA, White CW, Nick HJ, Rioux JS, Veress LA, Logue BA. Identification and determination of phenyl methyl carbamate released from adducted hemoglobin for methyl isocyanate exposure verification. J Chromatogr A. 2022 Oct 11;1681:463454. PubMed PMID: 36099696
  • Liptzin DR, McGraw MD, Houin PR, Veress LA. Fibrin airway cast obstruction: Experience, classification, and treatment guideline from Denver. Pediatr Pulmonol. 2022 Feb;57(2):529-537. PubMed PMID: 34713989
  • Nick HJ, Rioux JS, Veress LA, Bratcher PE, Bloomquist LA, Anantharam P, Croutch CR, Tuttle RS, Peters E, Sosna W, White CW. Alleviation of methyl isocyanate-induced airway obstruction and mortality by tissue plasminogen activator. Ann N Y Acad Sci. 2020 Nov;1479(1):134-147. PubMed PMID: 32233099
  • Wang J, Hajizadeh N, Moore EE, McIntyre RC, Moore PK, Veress LA, Yaffe MB, Moore HB, Barrett CD. Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series. J Thromb Haemost. 2020 Jul;18(7):1752-1755. PubMed PMID: 32267998
  • McGraw MD, Kim SY, White CW, Veress LA. Acute cytotoxicity and increased vascular endothelial growth factor after in vitro nitrogen mustard vapor exposure. Ann N Y Acad Sci. 2020 Nov;1479(1):223-233. PubMed PMID: 32408394
  • Barrett CD, Moore HB, Moore EE, McIntyre RC, Moore PK, Burke J, Hua F, Apgar J, Talmor DS, Sauaia A, Liptzin DR, Veress LA, Yaffe MB. Fibrinolytic therapy for refractory COVID-19 acute respiratory distress syndrome: Scientific rationale and review. Res Pract Thromb Haemost. 2020 May;4(4):524-531. PubMed PMID: 32542213
  • Rancourt RC, Rioux JS, Veress LA, Garlick RB, Croutch CR, Peters E, Sosna W, White CW. Methyl isocyanate inhalation induces tissue factor-dependent activation of coagulation in rats. Drug Chem Toxicol. 2019 May;42(3):321-327. PubMed PMID: 30426789
  • Rancourt RC, Rioux JS, Veress LA, Garlick RB, Croutch CR, Peters E, Sosna W, White CW. Methyl isocyanate inhalation induces tissue factor-dependent activation of coagulation in rats. Drug Chem Toxicol. 2018 Nov 14;:1-7. [Epub ahead of print] PubMed PMID: 30426789
  • Manandhar E, Pay A, Veress LA, Logue BA. Rapid analysis of sulfur mustard oxide in plasma using gas chromatography-chemical ionization-mass spectrometry for diagnosis of sulfur mustard exposure. J Chromatogr A. 2018 Oct 19;1572:106-111. PubMed PMID: 30170867
  • McGraw MD, Veress LA. Reply to: Comment on "Bronchiolitis Obliterans and Pulmonary Fibrosis after Sulfur Mustard Inhalation in Rats". Am J Respir Cell Mol Biol. 2018 Aug;59(2):274-275. PubMed PMID: 30067093
  • Logue BA, Zhang Z, Manandhar E, Pay AL, Croutch CR, Peters E, Sosna W, Rioux JS, Veress LA, White CW. Determination of methyl isopropyl hydantoin from rat erythrocytes by gas-chromatography mass-spectrometry to determine methyl isocyanate dose following inhalation exposure. J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Sep 1;1093-1094:119-127. PubMed PMID: 30015309
  • Miao Y, Jing JC, Desai V, Mahon SB, Brenner M, Veress LA, White CW, Chen Z. Automated 3D segmentation of methyl isocyanate-exposed rat trachea using an ultra-thin, fully fiber optic optical coherence endoscopic probe. Sci Rep. 2018 Jun 7;8(1):8713. PubMed PMID: 29880863
  • Liptzin DR, Di Maria MV, Younoszai A, Narkewicz MR, Kelly SL, Wolfe KR, Veress LA. Pulmonary Screening in Subjects after the Fontan Procedure. J Pediatr. 2018 Aug;199:140-143. PubMed PMID: 29747936
  • McGraw MD, Dysart MM, Hendry-Hofer TB, Houin PR, Rioux JS, Garlick RB, Loader JE, Smith R, Paradiso DC, Holmes WW, Anderson DR, White CW, Veress LA. Bronchiolitis Obliterans and Pulmonary Fibrosis after Sulfur Mustard Inhalation in Rats. Am J Respir Cell Mol Biol. 2018 Jun;58(6):696-705. PubMed PMID: 29314868
  • Okponyia OC, McGraw MD, Dysart MM, Garlick RB, Rioux JS, Murphy AL, Roe GB, White CW, Veress LA. Oxygen Administration Improves Survival but Worsens Cardiopulmonary Functions in Chlorine-exposed Rats. Am J Respir Cell Mol Biol. 2018 Jan;58(1):107-116. PubMed PMID: 28846437
  • McGraw MD, Osborne CM, Mastej EJ, Di Paola JA, Anderson DR, Holmes WW, Paradiso DC, Garlick RB, Hendry-Hofer TB, Rancourt RC, Smith RW, Burns C, Roe GB, Rioux JS, White CW, Veress LA. Editor's Highlight: Pulmonary Vascular Thrombosis in Rats Exposed to Inhaled Sulfur Mustard. Toxicol Sci. 2017 Oct 1;159(2):461-469. PubMed PMID: 28962529
  • DePopas EM, Veress LA, Ahmed F, Rausch CM, Annam A, Gupta R. Percutaneous thoracic duct intervention to treat plastic bronchitis related to Fontan palliation. Pediatr Pulmonol. 2017 Nov;52(11):E97-E101. PubMed PMID: 28869334
  • Okponyia OC, McGraw MD, Dysart MM, Garlick RB, Rioux JS, Murphy AL, Roe GB, White CW, Veress LA. Oxygen Administration Improves Survival but Worsens Cardiopulmonary Functions in Chlorine Exposed Rats. Am J Respir Cell Mol Biol. 2017 Aug 28. [Epub ahead of print] PubMed PMID: 28846437
  • Summerhill EM, Hoyle GW, Jordt SE, Jugg BJ, Martin JG, Matalon S, Patterson SE, Prezant DJ, Sciuto AM, Svendsen ER, White CW, Veress LA. An Official American Thoracic Society Workshop Report: Chemical Inhalational Disasters. Biology of Lung Injury, Development of Novel Therapeutics, and Medical Preparedness. Ann Am Thorac Soc. 2017 Jun;14(6):1060-1072. PubMed PMID: 28418689
  • McGraw MD, Rioux JS, Garlick RB, Rancourt RC, White CW, Veress LA. From the Cover: ImpairedProliferation and Differentiation of the Conducting Airway Epithelium Associated With Bronchiolitis Obliterans After Sulfur Mustard Inhalation Injury in Rats. Toxicol Sci. 2017 Jun 1;157(2):399-409. PubMed PMID: 28402575
  • White CW, Rancourt RC, Veress LA. Sulfur mustard inhalation: mechanisms of injury, alteration of coagulation, and fibrinolytic therapy. Ann N Y Acad Sci. 2016 Aug;1378(1):87-95. PubMed PMID: 27384912
  • McElroy CS, Min E, Huang J, Loader JE, Hendry-Hofer TB, Garlick RB, Rioux JS, Veress LA, Smith R, Osborne C, Anderson DR, Holmes WW, Paradiso DC, White CW, Day BJ. From the Cover: Catalytic Antioxidant Rescue of Inhaled Sulfur Mustard Toxicity. Toxicol Sci. 2016 Dec;154(2):341-353. PubMed PMID: 27605419
  • White CW, Rancourt RC, Veress LA. Sulfur mustard inhalation: mechanisms of injury, alteration of coagulation, and fibrinolytic therapy. Ann N Y Acad Sci. 2016 Aug;1378(1):87-95. PubMed PMID: 27384912
  • Veress LA, Anderson DR, Hendry-Hofer TB, Houin PR, Rioux JS, Garlick RB, Loader JE, Paradiso DC, Smith RW, Rancourt RC, Holmes WW, White CW. Airway tissue plasminogen activator prevents acute mortality due to lethal sulfur mustard inhalation. Toxicol Sci. 2015 Jan;143(1):178-84. PubMed PMID: 25331496
  • Houin PR, Veress LA, Rancourt RC, Hendry-Hofer TB, Loader JE, Rioux JS, Garlick RB, White CW. Intratracheal heparin improves plastic bronchitis due to sulfur mustard analog. Pediatr Pulmonol. 2015 Feb;50(2):118-26. PubMed PMID: 24692161
  • Veress LA, Anderson DR, Hendry-Hofer TB, Houin PR, Rioux JS, Garlick RB, Loader JE, Paradiso DC, Smith RW, Rancourt RC, Holmes WW, White CW. Airway tissue plasminogen activator prevents acute mortality due to lethal sulfur mustard inhalation. Toxicol Sci. 2015 Jan;143(1):178-84. PubMed PMID: 25331496
  • Ahmad S, Ahmad A, Hendry-Hofer TB, Loader JE, Claycomb WC, Mozziconacci O, Schöneich C, Reisdorph N, Powell RL, Chandler JD, Day BJ, Veress LA, White CW. Sarcoendoplasmic reticulum Ca(2 ) ATPase. A critical target in chlorine inhalation-induced cardiotoxicity. Am J Respir Cell Mol Biol. 2015 Apr;52(4):492-502. PubMed PMID: 25188881
  • Houin PR, Veress LA, Rancourt RC, Hendry-Hofer TB, Loader JE, Rioux JS, Garlick RB, White CW. Intratracheal heparin improves plastic bronchitis due to sulfur mustard analog. Pediatr Pulmonol. 2015 Feb;50(2):118-26. PubMed PMID: 24692161
  • Veress LA, Anderson DR, Hendry-Hofer TB, Houin PR, Rioux JS, Garlick RB, Loader JE, Paradiso DC, Smith RW, Rancourt RC, Holmes WW, White CW. Airway tissue plasminogen activator prevents acute mortality due to lethal sulfur mustard inhalation. Toxicol Sci. 2015 Jan;143(1):178-84. PubMed PMID: 25331496
  • Ahmad S, Ahmad A, Hendry-Hofer TB, Loader JE, Claycomb WC, Mozziconacci O, Schöneich C, Reisdorph N, Powell RL, Chandler JD, Day BJ, Veress LA, White CW. Sarcoendoplasmic reticulum Ca(2 ) ATPase. A critical target in chlorine inhalation-induced cardiotoxicity. Am J Respir Cell Mol Biol. 2015 Apr;52(4):492-502. PubMed PMID: 25188881
  • Houin PR, Veress LA, Rancourt RC, Hendry-Hofer TB, Loader JE, Rioux JS, Garlick RB, White CW. Intratracheal heparin improves plastic bronchitis due to sulfur mustard analog. Pediatr Pulmonol. 2015 Feb;50(2):118-26. PubMed PMID: 24692161
  • Ahmad S, Ahmad A, Hendry-Hofer TB, Loader JE, Claycomb WC, Mozziconacci O, Schöneich C, Reisdorph N, Powell RL, Chandler JD, Day BJ, Veress LA, White CW. SERCA: A Critical Target in Chlorine Inhalation-induced Cardiotoxicity. Am J Respir Cell Mol Biol. 2014 Sep 4. [Epub ahead of print] PubMed PMID: 25188881
  • Ahmad S, Ahmad A, Neeves KB, Hendry-Hofer T, Loader JE, White CW, Veress L. In vitro cell culture model for toxic inhaled chemical testing. J Vis Exp. 2014 May 8;(87). PubMed PMID: 24837339
  • Rancourt RC, Ahmad A, Veress LA, Rioux JS, Garlick RB, White CW. Antifibrinolytic mechanisms in acute airway injury after sulfur mustard analog inhalation. Am J Respir Cell Mol Biol. 2014 Oct;51(4):559-67. PubMed PMID: 24796565
  • Rancourt RC, Veress LA, Ahmad A, Hendry-Hofer TB, Rioux JS, Garlick RB, White CW. Tissue factor pathway inhibitor prevents airway obstruction, respiratory failure and death due to sulfur mustard analog inhalation. Toxicol Appl Pharmacol. 2013 Oct 1;272(1):86-95. PubMed PMID: 23727623
  • Veress LA, Hendry-Hofer TB, Loader JE, Rioux JS, Garlick RB, White CW. Tissue plasminogen activator prevents mortality from sulfur mustard analog-induced airway obstruction. Am J Respir Cell Mol Biol. 2013 Apr;48(4):439-47. PubMed PMID: 23258228
  • Veress LA, Hendry-Hofer TB, Loader JE, Rioux JS, Garlick RB, White CW. Tissue Plasminogen Activator Prevents Mortality from Sulfur Mustard Analog-Induced Airway Obstruction. Am J Respir Cell Mol Biol. 2012 Dec 20. [Epub ahead of print] PubMed PMID: 23258228
  • Rancourt RC, Veress LA, Guo X, Jones TN, Hendry-Hofer TB, White CW. Airway tissue factor-dependent coagulation activity in response to sulfur mustard analog 2-chloroethyl ethyl sulfide. Am J Physiol Lung Cell Mol Physiol. 2012 Jan 1;302(1):L82-92. PubMed PMID: 21964405
View All (39 Total) View Less

Professional Memberships

  • American Thoracic Society (ATS), Member
  • American Medical Association, Member
  • American Academy of Pediatrics (AAP), Resident Fellow
  • EAPCCT, Member
  • SOT, Full Member

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave
Aurora, CO 80045
720-777-1234

Hospital Affiliation
  • Children's Hospital Colorado

Specialty Information

Specialties
  • Pediatrics, Board Certification (2005)
  • Pediatric Critical Care Medicine
  • Pediatric Pulmonology (2010)
Conditions & Treatments
  • Lungs and Breathing - Pulmonary Disorders
  • Lungs and Breathing
  • Altitude Medicine
  • Lungs and Breathing - Pulmonary Hypertension
  • Lungs and Breathing - Respiratory Disease
  • Lungs and Breathing - Tracheostomy Dependence
  • Lungs and Breathing - Pulmonary Embolism
  • Lungs and Breathing - Obstructive Sleep Apnea
  • Lungs and Breathing - Neonatal Lung Diseases
  • Lungs and Breathing - Lung Disease
  • Lungs and Breathing - Interventional Pulmonology
  • Lungs and Breathing - Interstitial Lung Disease
  • Lungs and Breathing - Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
  • Lungs and Breathing - Chronic Mechanical Ventilation
  • Lungs and Breathing - Chronic Lung Disease of Prematurity (Bronchopulmonary Dysplasia)
Clinical Interests
My many clinical interests include Airway coagulation disorders, Plastic bronchitis, Pulmonary fibrosis, Airway Fibrosis, Airway anatomic abnormalities,

Care Philosophy
I strive to provide an extremely thorough care for all my patients. I believe in treating the person as a whole, taking every aspect of a patient’s body and health into consideration during diagnosis and treatment.

General Information

Medical Schools:
  • MD, Louisiana State University School of Medicine in New Orleans (2002)
Undergraduate Schools:
  • BS, Tulane University (LA) (1996)
Residency Programs:
  • Louisiana State University Program, Pediatrics (2006)
Fellowships:
  • University of Colorado, Pediatric Critical Care Medicine (2006)
  • University of Colorado, Pediatric Pulmonology (2010)
Languages: English, Hungarian
Department: Pediatrics-Pulmonary Medicine
SOM Resources
CU Resources
Contact Us
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Campus Box C290
Aurora, CO 80045

Update My Profile
;